大豆油体与EGF融合基因的克隆及其在红花种子中的表达

目的：旨在建立一种在红花油体中表达EGF的转基因植物的方法。方法：通过PCR技术把大豆油体基因（DDoil）与EGF构建成融合基因,克隆至植物表达载体pCAMBIA1390R中,构建成植物表达载体p1390Do-EGF,然后转化进农杆菌 LBA4404 中用于侵染红花外植体,通过甘露糖筛选培养基培养可获得红花转化苗。通过PCR、实时荧光相对定量RT-PCR、SDS-PAGE和Western blot分析目的基因的表达情况,通过MTT法检测EGF的促细胞增殖活性。结果：PCR结果显示,红花叶片中能检测到EGF基因;实时荧光相对定量RT-PCR结果显示,在红花种子中EGF能成功实现转录;SDS-PAGE和Western blot检测证明,在转基因红花种子中能有效表达出EGF,并具有其原有的免疫原性,MTT法实验结果表明EGF具有促进balb/c 3T3细胞增殖的生物活性。结论：大豆油体和EGF融合基因已经成功转化进红花细胞的基因组中,并实现了EGF外源蛋白在红花种子油体中的表达,为EGF蛋白的产业化生产探讨了一种新的生产途径。     

人角质细胞生长因子2真核表达载体的构建及功能验证

目的:构建人角质细胞生长因子2(KGF-2)基因真核表达载体,探索KGF-2的上皮细胞迁移功能。方法:以人乳腺cDNA文库为模板,PCR扩增KGF-2基因片段,将其插入pXJ-40-myc,经双酶切和测序验证后,将重组质粒转染HEK-293T细胞,采用Western印迹检测重组蛋白;转染人肠上皮细胞FHC,采用细胞划痕实验检测细胞迁移能力。结果:PCR扩增获得627 bp的DNA产物,插入pXJ-40-myc载体,双酶切及测序结果证明重组质粒含有目的序列;转染HEK-293T细胞,Western印迹检测到相对分子质量约23×103的目的蛋白;细胞划痕实验显示,转染Myc-KGF-2的FHC细胞较未转染或转染空载体的细胞迁移能力强。结论:构建了人KGF-2基因真核表达载体,并验证了其促进细胞迁移的功能。     

转基因红花中角质细胞生长因子KGF-1的表达

通过构建重组表达质粒载体p139035S-KGF1和根癌农杆菌介导在红花（Carthamus tinctorius）中表达角质细胞生长因子（KGF-1）。从侵染到诱导生根共需要14周,转化率达0.1%。红花子叶在潮霉素筛选培养基上培养4-5周后便可获得丛生芽,再生芽移入含潮霉素的伸长生根培养基,培养4-8周可诱导生根。通过PCR、Southern blot、RT-PCR及Western blot检测证明目的基因KGF-1已经整合到红花细胞的染色体中,实现了KGF-1外源蛋白在红花中的成功表达,为开发KGF-1蛋白新的生产途径奠定了基础。     

转基因红花中角质细胞生长因子KGF-1的表达

通过构建重组表达质粒载体p139035S-KGF1和根癌农杆菌介导在红花(Carthamus tinctorius)中表达角质细胞生长因子(KGF-1)。从侵染到诱导生根共需要14周, 转化率达0.1%。红花子叶在潮霉素筛选培养基上培养4–5周后便可获得丛生芽, 再生芽移入含潮霉素的伸长生根培养基, 培养4–8周可诱导生根。通过PCR、Southern blot、RT-PCR及Western blot检测证明目的基因KGF-1已经整合到红花细胞的染色体中, 实现了KGF-1外源蛋白在红花中的成功表达, 为开发KGF-1蛋白新的生产途径奠定了基础。     

PHD2基因原核表达载体的构建及其在大肠埃希菌中的表达

目的构建PHD2基因原核表达载体pET-43.1b（＋）-PHD2,实现Nus-PHD2融合蛋白在大肠埃希菌中的可溶性表达。方法用SacⅠ酶切pET-43.1b（＋）制备线性化载体,设计与线性化载体两端具有至少15个同源序列的特异性引物,以真核重组质粒pCMV6-Entry-EGLN1为模板,PCR法扩增PHD2目的基因。采用In-Fusion技术构建原核表达载体pET-43.1b（＋）-PHD2,并将其导入大肠埃希菌BL21（DE3）中诱导表达。用SDS-PAGE和Western blot分析并鉴定表达出的融合蛋白。用Ni-NTA亲和层析法纯化目的蛋白。结果成功构建了PHD2原核表达载体;SDS-PAGE结果显示融合蛋白以可溶性形式表达;Western blot鉴定表明融合蛋白可以与PHD2单克隆抗体特异性结合。结论实现了Nus-PHD2融合蛋白在大肠埃希菌中的可溶性表达,为PHD2生物学功能的研究奠定了基础。     

pLNCX-pemt2重组载体的构建及pemt2基因在大鼠肝癌CBRH-7919细胞中的表达

为进一步研究 pemt2对肝癌细胞生长抑制的作用机制提供方便的实验模型 ,构建了p LNCX- pemt2重组体 .将目的基因 pemt2连接入含有 neo抗性基因的真核细胞表达载体 p LNCX中 ,构建 p LNCX- pemt2重组子 ,并用磷酸钙沉淀法将其转入大鼠肝癌 CBRH- 791 9细胞中 ,应用PCR、Western印迹及 [3 H]SAM参入等技术对其转染、表达及活性进行鉴定 .转染 p LNCX- pemt2的大鼠肝癌细胞 ,PEMT2成功表达 (分子量为 2 2 .5k D) ;高表达克隆 PEMT2的表达量比对照组高约 5倍 ,其活性比对照组高 2 .1倍 ;细胞生长的倍增时间从 2 1 .54± 7.0 8h延长到 43.2 2± 7.1 1h.结果表明 ,p LNCX- pemt2重组体转入肝癌细胞后 ,PEMT2蛋白得到高效表达 ,明显抑制肝癌细胞生长 .     

人Pokemon蛋白锌指结构域的表达与纯化

旨在原核表达Pokemon基因的锌指结构域,纯化获得GST-Zinc finger的融合蛋白。以人胶质瘤T98G细胞的c DNA为模板,利用PCR扩增带有Bam H I和Sal I酶切位点的人Pokemon基因的锌指结构域,然后将其克隆到p GEX-4T-1原核表达载体中。将正确的重组载体转入大肠杆菌BL21(DE3),用IPTG诱导表达,再利用Magne GST particles亲和纯化Zinc finger融合蛋白,最后通过Western blot鉴定此融合蛋白。结果显示,成功构建p GEX-4T-1-Zinc finger原核表达载体;30℃条件下,0.2 mmol/L的IPTG能诱导出大量的可溶性GST-Zinc finger蛋白;经Magne GST particles纯化的GST-Zinc finger蛋白可被识别Pokemon锌指结构域的抗体特异识别。纯化的GST-Zinc finger蛋白可用于后续的生物学研究。     

富亮氨酸重复超家族新成员LRRC4的IgC2结构域蛋白的原核表达和纯化

富亮氨酸重复超家族新成员LRRC4基因是新克隆的脑瘤相关基因,采用多聚酶链式反应（PCR）方法获得长约500bp含IgC2结构域的DNA序列,扩增产物克隆至pGEX-4T-2质粒中,构建GST融合表达质粒,在大肠杆菌中诱导表达融合蛋白,经包涵体沉淀,溶解,Glutathione-Sepharose亲和层析纯化获得融合蛋白,并以Western blot鉴定证实,通过IgC2结构域蛋白的纯化分离该结构域,为进一步研究该结构域及LRRC4基因的结构和功能奠定了基础。     

重组大肠杆菌表达水稻白叶枯病菌FtsZ蛋白

旨在通过现代分子生物学技术制备水稻白叶枯病菌FtsZ蛋白。以水稻白叶枯病菌总DNA为模板,采用巢式PCR方法扩增获得水稻白叶枯病菌fts Z基因,构建fts Z基因的表达载体p ET-22b-ftsZ,转化表达宿主E.coli BL21后,经PCR、Nde I/Xho I双酶切及测序鉴定、阳性克隆子经IPTG诱导表达,融合蛋白经镍柱纯化后,通过SDS-PAGE和Western blotting分析鉴定。结果显示,水稻白叶枯病菌ftsZ基因的重组表达载体构建成功,且阳性克隆子在IPTG的诱导下表达了Fts Z-6×His融合蛋白,并通过镍柱纯化获得了电泳纯的Fts Z-6×His融合蛋白。     

应用2A肽策略构建双基因共表达转基因斑马鱼的研究

目的以Tol2为骨架载体,以绿色荧光蛋白(GFP)、Cherry为报告基因,探讨采用2A肽双基因载体构建策略构建单启动子双基因共表达质粒的方法;将B细胞刺激因子(BAFF)分别置于2A序列前后位置,分析位置效应对跨膜融合蛋白的表达与剪切的影响,探讨多基因共表达转基因斑马鱼构建技术。方法以In Fusion法将GFP-2A-Cherry序列构建到Tol2质粒上,所得p Tol-GFP-2A-Cherry质粒转染He La细胞、显微注射1-细胞期斑马鱼受精卵;倒置荧光显微镜观察He La细胞、斑马鱼幼鱼体内GFP与Cherry蛋白的表达,Western blot法验证GFP和Cherry蛋白的表达量与剪切情况;分别构建p Tol2-GFP-2A-BAFF与p Tol2-BAFF-2A-Cherry质粒,Western blot法检查BAFF的表达与剪切情况。结果 p Tol2-GFP-2A-Cherry质粒转染的He La细胞,GFP与Cherry均可单独表达且表达呈现时空一致性;GFP-2A-Cherry融合蛋白可被剪切为GFP与Cherry,且成等比例表达趋势。p Tol2-GFP-2A-Cherry质粒显微注射1-细胞期斑马鱼受精卵可获得可单独表达GFP与Cherry蛋白的转基因斑马鱼;p Tol2-GFP-2A-BAFF与p Tol2-BAFF-2A-Cherry于斑马鱼体内均有融合蛋白的表达,且BAFF序列位于2A序列后更易于融合蛋白的剪切。结论通过2A肽策略构建可实现在斑马鱼体内单一载体、单一启动子调控双基因表达目的。发现编码跨膜分泌蛋白的功能基因位于2A序列的不同位置会直接影响蛋白的剪切,功能基因位于2A序列后易于跨膜蛋白的剪切。     

MTT实验检测重组人角质细胞生长因子-2诱导不同细胞系增殖的差异

目的:用MTT法检测重组人角质细胞生长因子-2(rhKGF-2)诱导不同细胞系增殖的差异,建立验证rhKGF-2生物活性的细胞模型.方法:利用载体pBV220-KGF-2原核表达和纯化rhKGF-2,然后用MTT法分别检测rhKGF-2诱导大鼠气管上皮细胞RTE、大鼠小肠上皮细胞IEC-6、小鼠成纤维细胞NIH/3T3...     

Stimulation of Human Hair Growth by the Recombinant Human Keratinocyte Growth Factor-2 (KGF-2)

Keratinocyte growth factor-2 (KGF-2) is found in dermal papilla fibroblasts and its receptor, fibroblast growth factor receptor 2 (FGFR2), in the neighboring outer root sheath of keratinocytes. Administration of recombinant human KGF-2 (rhKGF-2) at 10 ng ml⁻¹ significantly stimulated human hair-follicle cell proliferation in organ culture (26–35%). Thus, rhKGF-2 is a promising therapeutic agent to stimulate human hair growth.     

角质细胞生长因子2对细胞生长、移行及创伤愈合的作用

角质细胞生长因子2(KGF-2)是成纤维细胞生长因子超家族的一员,由间质细胞合成并分泌,能特异促进上皮细胞增殖、分化与迁移,对脊椎动物多种组织和器官的发育起重要调控作用．通过PCR从人的肾组织cDNA文库中克隆分离获得了KGF-2的cDNA,表明该因子在成人肾中有表达．采用大肠杆菌表达并纯化重组蛋白用于生物学功能研究的结果显示：KGF-2在体外不仅能够促进角质细胞的生长和增殖,而且对其凋亡具有抑制作用,还对细胞的移行具有影响．在动物实验中,KGF-2能促进皮肤切除产生的伤口愈合,提示该蛋白质可以作为创伤治疗或辅助用药的候选分子．     

Noncovalent PEGylation by polyanion complexation as a means to stabilize keratinocyte growth factor-2 (KGF-2)

Repifermin, a truncated form of fibroblast growth factor-10 (FGF-10) also known as keratinocyte growth factor-2 (KGF-2), is a heparin-binding protein with potent regenerative properties. The protein unfolds and aggregates at relatively low temperature (~37 °C). Electrostatic interactions between polyanions and several FGFs have been reported to enhance the thermal stability of these proteins. Polyethylene glycol (PEG) was grafted to the polyanions pentosan polysulfate (PPS) and dextran sulfate (DS) as an alternative means to stabilize and noncovalently PEGylate KGF-2. Physical characteristics of KGF-2:polyanion-PEG complexes were examined using a variety of methods including circular dichroism (CD), intrinsic tryptophan fluorescence, differential scanning calorimetry, and dynamic light scattering. When compared to KGF-2 alone, subtle changes in CD spectra and fluorescence emission maxima were found when KGF-2 was formulated with the synthetic PEG-polyanions. Highly PEGylated polyanions (DS-PEG5) did not bind KGF-2 as well as conjugates with fewer PEG chains. The molecular weight of PEG did not have a noticeable effect on KGF-2 binding to the various PEG-polyanion conjugates. At optimal molar ratios, PPS-PEG and DS-PEG conjugates were able to stabilize KGF-2 by increasing the melting temperature by approximately 9-17 °C. Thus, polyanion-PEG conjugates improved the stability of KGF-2 and also offered a new electrostatic PEGylation scheme that may be extrapolated to other heparin-binding proteins.     

Neuroprotective roles of the P2Y2 receptor

Purinergic signaling plays a unique role in the brain by integrating neuronal and glial cellular circuits. The metabotropic P1 adenosine receptors and P2Y nucleotide receptors and ionotropic P2X receptors control numerous physiological functions of neuronal and glial cells and have been implicated in a wide variety of neuropathologies. Emerging research suggests that purinergic receptor interactions between cells of the central nervous system (CNS) have relevance in the prevention and attenuation of neurodegenerative diseases resulting from chronic inflammation. CNS responses to chronic inflammation are largely dependent on interactions between different cell types (i.e., neurons and glia) and activation of signaling molecules including P2X and P2Y receptors. Whereas numerous P2 receptors contribute to functions of the CNS, the P2Y(2) receptor is believed to play an important role in neuroprotection under inflammatory conditions. While acute inflammation is necessary for tissue repair due to injury, chronic inflammation contributes to neurodegeneration in Alzheimer's disease and occurs when glial cells undergo prolonged activation resulting in extended release of proinflammatory cytokines and nucleotides. This review describes cell-specific and tissue-integrated functions of P2 receptors in the CNS with an emphasis on P2Y(2) receptor signaling pathways in neurons, glia, and endothelium and their role in neuroprotection.     

BCL2A1: the underdog in the BCL2 family

B-cell lymphoma 2 (BCL2) proteins are important cell death regulators, whose main function is to control the release of cytochrome c from mitochondria in the intrinsic apoptotic pathway. They comprise both pro- and anti-apoptotic proteins, which interact in various ways to induce or prevent pore formation in the outer mitochondrial membrane. Due to their central function in the apoptotic machinery, BCL2 proteins are often deregulated in cancer. To this end, many anti-apoptotic BCL2 proteins have been identified as important cellular oncogenes and attractive targets for anti-cancer therapy. In this review, the existing knowledge on B-cell lymphoma 2-related protein A1 (BCL2A1)/Bcl-2-related gene expressed in fetal liver (Bfl-1), one of the less extensively studied anti-apoptotic BCL2 proteins, is summarized. BCL2A1 is a highly regulated nuclear factor κB (NF-κB) target gene that exerts important pro-survival functions. In a physiological context, BCL2A1 is mainly expressed in the hematopoietic system, where it facilitates survival of selected leukocytes subsets and inflammation. However, BCL2A1 is overexpressed in a variety of cancer cells, including hematological malignancies and solid tumors, and may contribute to tumor progression. Therefore, the development of small molecule inhibitors of BCL2A1 may be a promising approach mainly to sensitize tumor cells for apoptosis and thus improve the efficiency of anti-cancer therapy.